1. Pentoxifylline Therapy for Hepatopulmonary Syndrome: A Pilot Study.
- Author
-
Gupta, Lal Babu, Kumar, Ashish, Jaiswal, Ashish Kumar, Yusuf, Jamal, Mehta, Vimal, Tyagi, Sanjay, Tempe, Deepak K., Sharma, Barjesh Chander, and Sarin, Shiv Kumar
- Subjects
- *
CLINICAL trials , *PENTOXIFYLLINE , *ANTI-inflammatory agents , *LUNG diseases , *LIVER diseases , *CIRRHOSIS of the liver , *HYPOXEMIA , *MEDICAL research , *VASODILATORS - Abstract
The article focuses on the prospective and nonrandomized clinical trial study regarding the use of pentoxifylline therapy in the management of Hepatopulmonary syndrome (HPS). It explains that HPS is prevalent among patients with cirrhosis, which is characterized by a triad of liver disease, hypoxemia and intrapulmonary vascular dilations (IPVD). 400 mg of Pentoxifylline was administered to patients three times daily for about 3 months. Adverse effects of the penotoxifylline was also monitored. Information on the other methodology and resutls is presented.
- Published
- 2008
- Full Text
- View/download PDF